Literature DB >> 7593468

No significant association between HLA antigens and classic Kaposi sarcoma: molecular analysis of 49 Jewish patients.

L Strichman-Almashanu1, S Weltfriend, O Gideoni, R Friedman-Birnbaum, S Pollack.   

Abstract

Because of the abundance of the classical form of Kaposi sarcoma (CKS) among Jews and people of Mediterranean origin, studies have been conducted to find an association between CKS and HLA antigens. No conclusive results have been drawn, although in a number of these investigations an increased incidence of HLA-DR5 was reported. In our study 49 CKS patients of Jewish origin were serologically analyzed for HLA class I and class II antigens. We found no significant deviation in serologically defined HLA antigens frequencies between patients and 99 ethnically matched controls. However, a nonsignificant decrease in the frequencies of HLA-DR4, HLA-DR12, and the combination of DR4/DR11 was observed. Then we determined in these patients HLA-DRB1, HLA-DQA1, and DQB1 allelic polymorphism by oligotyping on PCR-amplified DNA. In this molecular analysis the only notable finding was a decreased frequency of the combination HLA-DQA1*0301/DQB1*0301, which appeared in one (2%) patient compared to 13 (13%) of the controls. However, the decrease was not statistically significant. On the basis of both serological and molecular analysis done on a relatively large group of CKS patients, we conclude that there is no significant linkage between HLA antigens and CKS in Jewish population.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7593468     DOI: 10.1007/BF01541091

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  22 in total

Review 1.  A review of Kaposi's sarcoma.

Authors:  J Armes
Journal:  Adv Cancer Res       Date:  1989       Impact factor: 6.242

2.  No HLA antigen is significant in classic Kaposi's sarcoma.

Authors:  E E Tzfoni; L Scherman; S Battat; H Brautbar
Journal:  J Am Acad Dermatol       Date:  1993-01       Impact factor: 11.527

3.  Histocompatibility antigens HLA-A, -B, -DR in Greek patients with Kaposi's sarcoma.

Authors:  C Papasteriades; A Kaloterakis; A Filiotou; J Economidou; G Nicolis; D Trichopoulos; J Stratigos
Journal:  Tissue Antigens       Date:  1984-11

4.  Kaposi's sarcoma in Sardinia: an epidemiologic and genetic investigation.

Authors:  D Cerimele; L Contu; S Scappaticci; F Cottoni
Journal:  Ann N Y Acad Sci       Date:  1984       Impact factor: 5.691

5.  Absence of DRw15/3 and of DRw15/7 heterozygotes in Caucasian patients with systemic lupus erythematosus.

Authors:  D Reinharz; J M Tiercy; B Mach; M Jeannet
Journal:  Tissue Antigens       Date:  1991-01

6.  Frequencies of HLA and Gm immunogenetic markers in Kaposi's sarcoma.

Authors:  M S Pollack; B Safai; P L Myskowski; J W Gold; J Pandey; B Dupont
Journal:  Tissue Antigens       Date:  1983-01

Review 7.  Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus.

Authors:  E Thorsby; K S Rønningen
Journal:  Diabetologia       Date:  1993-05       Impact factor: 10.122

8.  Human leukocyte antigen associations in basal cell carcinoma.

Authors:  P L Myskowski; M S Pollack; E Schorr; B Dupont; B Safai
Journal:  J Am Acad Dermatol       Date:  1985-06       Impact factor: 11.527

9.  Immunologic and immunogenetic features of primary Kaposi's sarcoma.

Authors:  C Marinig; G Fiorini; V Boneschi; E Melotti; L Brambilla
Journal:  Cancer       Date:  1985-05-01       Impact factor: 6.860

Review 10.  Molecular basis of human leukocyte antigen class II disease associations.

Authors:  D Charron
Journal:  Adv Immunol       Date:  1990       Impact factor: 3.543

View more
  5 in total

1.  Relationship between human leukocyte antigen alleles and risk of Kaposi's sarcoma in Cameroon.

Authors:  Elena M Cornejo Castro; Brian J Morrison; Vickie A Marshall; Nazzarena Labo; Wendell J Miley; Nathan Clements; George Nelson; Paul Ndom; Kristen Stolka; Jennifer J Hemingway-Foday; Mahamat Abassora; Xiaojiang Gao; Jennifer S Smith; Mary Carrington; Denise Whitby
Journal:  Genes Immun       Date:  2019-05-20       Impact factor: 2.676

2.  Fifty-one Kaposi sarcoma patients.

Authors:  Mutlu Dogan; Lutfi Dogan; Feyyaz Ozdemir; Nuriye Yildirim Ozdemir; Hasan Senol Coskun; Ulku Yalcintas Arslan; Guze Ozal; Gungor Utkan; Ahmet Demirkazik; Fazil Aydin; Nurullah Zengin; Fikri Icli
Journal:  Clin Transl Oncol       Date:  2010-09       Impact factor: 3.405

Review 3.  Cancer in Jews: introduction and overview.

Authors:  Henry T Lynch; Wendy S Rubinstein; Gershon Y Locker
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

4.  Risk of Classic Kaposi Sarcoma With Combinations of Killer Immunoglobulin-Like Receptor and Human Leukocyte Antigen Loci: A Population-Based Case-control Study.

Authors:  James J Goedert; Maureen P Martin; Francesco Vitale; Carmela Lauria; Denise Whitby; Ying Qi; Xiaojiang Gao; Mary Carrington
Journal:  J Infect Dis       Date:  2015-08-12       Impact factor: 5.226

5.  Candidate Predisposition Variants in Kaposi Sarcoma as Detected by Whole-Genome Sequencing.

Authors:  Sanni J Rinne; Lauri J Sipilä; Päivi Sulo; Emmanuelle Jouanguy; Vivien Béziat; Laurent Abel; Jean-Laurent Casanova; Nima Parvaneh; Kamran Balighi; Emma Guttman-Yassky; Ronit Sarid; Lauri A Aaltonen; Mervi Aavikko
Journal:  Open Forum Infect Dis       Date:  2019-07-17       Impact factor: 3.835

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.